Trinity Biotech (TRIB) announced Tuesday morning that following a meeting with the FDA, it has decided to withdraw its 510(k) premarket notification submission for the Meritas Troponin-I Test and Meritas Point-of-Care Analyzer.
from RTT - Before the Bell http://ift.tt/2dJ6PkU
via IFTTT
No comments:
Post a Comment